Fucoidan from fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and Hepg2 cells

Marine Drugs

Volumn 13, Issue 2, 2015, Pages 1051-1067

  Lim, Jung Dae ^a   Lee, Sung Ryul ^b   Kim, Taeseong ^a   Jang, Seon A ^c   Kang, Se Chan ^c   Koo, Hyun Jung ^d   Sohn, Eunsoo ^e   Bak, Jong Phil ^f   Namkoong, Seung ^a   Kim, Hyoung Kyu ^b   Song, In Sung ^b   Kim, Nari ^b   Sohn, Eun Hwa ^a   Han, Jin ^b  

^a Kangwon National University   (South Korea)

^b Department of Physiology College of Medicine Cardiovascular and Metabolic Disease Center   (South Korea)

^c Gachon University   (South Korea)

^d Korea National College of Agriculture and Fisheries   (South Korea)

^e Korea Institute of Science and Technology Information (KISTI)   (South Korea)

^f Semyung University   (South Korea)

Author keywords

Alcohol; Cyclooxygenase 2; Fucoidan; Liver; Transforming growth factor beta 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CYCLOOXYGENASE 2; FUCOIDIN; HEME OXYGENASE 1; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA1; AUTACOID; CYCLOOXYGENASE 2 INHIBITOR; POLYSACCHARIDE; TGFB1 PROTEIN, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; ENZYME SYNTHESIS; FUCUS VESICULOSUS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPLEEN; THYMUS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CELL LINE; CHEMISTRY; DRUG EFFECTS; FUCUS; HEP-G2 CELL LINE; HEPATITIS, ALCOHOLIC; ISOLATION AND PURIFICATION; METABOLISM; ORGAN SIZE;

FUCUS VESICULOSUS; INVERTEBRATA; MURINAE; MUS; PHAEOPHYCEAE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CELL LINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FUCUS; HEME OXYGENASE-1; HEP G2 CELLS; HEPATITIS, ALCOHOLIC; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; ORGAN SIZE; POLYSACCHARIDES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84923261249     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13021051     Document Type: Article

References (45)

1. Room, R.; Babor, T.; Rehm, J. Alcohol and public health. Lancet 2005, 365, 519-530.
2. Park, S.H.; Kim, C.H.; Kim, D.J.; Park, J.H.; Kim, T.O.; Yang, S.Y.; Moon, Y.S.; Kim, T.N.; Kim, H.K.; Park, H.Y.; et al. Prevalence of alcoholic liver disease among Korean adults: results from the fourth Korea National Health and Nutrition Examination Survey, 2009. Subst. Use Misuse 2011, 46, 1755-1762.
3. Zamora Nava, L.E.; Aguirre Valadez, J.; Chavez-Tapia, N.C.; Torre, A. Acute-on-chronic liver failure: A review. Ther. Clin. Risk Manag. 2014, 10, 295-303.
4. Friedman, S.L. Liver fibrosis - From bench to bedside. J. Hepatol. 2003, 38 (Suppl. 1), S38-S53.
5. Kawaratani, H.; Tsujimoto, T.; Douhara, A.; Takaya, H.; Moriya, K.; Namisaki, T.; Noguchi, R.; Yoshiji, H.; Fujimoto, M.; Fukui, H. The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2013, 2013, 495156.
6. Tirapelli, L.F.; Batalhao, M.E.; Jacob-Ferreira, A.L.; Tirapelli, D.P.; Carnio, E.C.; Tanus-Santos, J.E.; Queiroz, R.H.; Uyemura, S.A.; Padovan, C.M.; Tirapelli, C.R. Chronic ethanol consumption induces histopathological changes and increases nitric oxide generation in the rat liver. Tissue Cell 2011, 43, 384-391.
7. De Bleser, P.J.; Niki, T.; Rogiers, V.; Geerts, A. Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J. Hepatol. 1997, 26, 886-893.
8. Baghy, K.; Iozzo, R.V.; Kovalszky, I. Decorin-TGFbeta axis in hepatic fibrosis and cirrhosis. J. Histochem. Cytochem. 2012, 60, 262-268.
9. Kyung-Oh, D. Effects of TGF-beta1 Ribbon Antisense on CCl(4)-induced Liver Fibrosis. Korean J. Physiol. Pharmacol. 2008, 12, 1-6.
10. Jung, Y.S.; Kim, S.J.; Kwon do, Y.; Ahn, C.W.; Kim, Y.S.; Choi, D.W.; Kim, Y.C. Alleviation of alcoholic liver injury by betaine involves an enhancement of antioxidant defense via regulation of sulfur amino acid metabolism. Food Chem. Toxicol. 2013, 62, 292-298.
11. Ganey, P.E.; Barton, Y.W.; Kinser, S.; Sneed, R.A.; Barton, C.C.; Roth, R.A. Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide. Toxicol. Appl. Pharmacol. 2001, 174, 113-121.
12. Jeong, S.W.; Jang, J.Y.; Lee, S.H.; Kim, S.G.; Cheon, Y.K.; Kim, Y.S.; Cho, Y.D.; Kim, H.S.; Lee, J.S.; Jin, S.Y.; et al. Increased expression of cyclooxygenase-2 is associated with the progression to cirrhosis. Korean J. Intern. Med. 2010, 25, 364-371.
13. Baraona, E.; Zeballos, G.A.; Shoichet, L.; Mak, K.M.; Lieber, C.S. Ethanol consumption increases nitric oxide production in rats, and its peroxynitrite-mediated toxicity is attenuated by polyenylphosphatidylcholine. Alcohol. Clin. Exp. Res. 2002, 26, 883-889.
14. Morse, D.; Lin, L.; Choi, A.M.; Ryter, S.W. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol. Med. 2009, 47, 1-12.
15. Park, S.Y.; Bae, J.U.; Hong, K.W.; Kim, C.D. HO-1 Induced by Cilostazol Protects Against TNF-alpha-associated Cytotoxicity via a PPAR-gamma-dependent Pathway in Human Endothelial Cells. Korean J. Physiol. Pharmacol. 2011, 15, 83-88.
16. Clement, M.J.; Tissot, B.; Chevolot, L.; Adjadj, E.; Du, Y.; Curmi, P.A.; Daniel, R. NMR characterization and molecular modeling of fucoidan showing the importance of oligosaccharide branching in its anticomplementary activity. Glycobiology 2010, 20, 883-894.
17. Cumashi, A.; Ushakova, N.A.; Preobrazhenskaya, M.E.; D'Incecco, A.; Piccoli, A.; Totani, L.; Tinari, N.; Morozevich, G.E.; Berman, A.E.; Bilan, M.I.; et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007, 17, 541-552.
18. Fitton, J.H. Therapies from fucoidan; multifunctional marine polymers. Mar. Drugs 2011, 9, 1731-1760.
19. Nakazato, K.; Takada, H.; Iha, M.; Nagamine, T. Attenuation of N-nitrosodiethylamine-induced liver fibrosis by high-molecular-weight fucoidan derived from Cladosiphon okamuranus. J. Gastroenterol. Hepatol. 2010, 25, 1692-1701.
20. Senni, K.; Gueniche, F.; Foucault-Bertaud, A.; Igondjo-Tchen, S.; Fioretti, F.; Colliec-Jouault, S.; Durand, P.; Guezennec, J.; Godeau, G.; Letourneur, D. Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. Arch. Biochem. Biophys. 2006, 445, 56-64.
21. Thring, T.S.; Hili, P.; Naughton, D.P. Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants. BMC Complement. Altern. Med. 2009, 9, 27.
22. Hayashi, S.; Itoh, A.; Isoda, K.; Kondoh, M.; Kawase, M.; Yagi, K. Fucoidan partly prevents CCl4-induced liver fibrosis. Eur. J. Pharmacol. 2008, 580, 380-384.
23. Saito, A.; Yoneda, M.; Yokohama, S.; Okada, M.; Haneda, M.; Nakamura, K. Fucoidan prevents concanavalin A-induced liver injury through induction of endogenous IL-10 in mice. Hepatol. Res. 2006, 35, 190-198.
24. Meenakshi, S.; Umayaparvathi, S.; Saravanan, R.; Manivasagam, T.; Balasubramanian, T. Hepatoprotective effect of fucoidan isolated from the seaweed Turbinaria decurrens in ethanol intoxicated rats. Int. J. Biol. Macromol. 2014, 67, 367-372.
25. Pruett, S.B.; Han, Y.C.; Wu, W.J. A brief review of immunomodulation caused by acute administration of ethanol: Involvement of neuroendocrine pathways. Alcohol. Alcohol. Suppl. 1994, 2, 431-437.
26. Wang, J.F.; Spitzer, J.J. Alcohol-induced thymocyte apoptosis is accompanied by impaired mitochondrial function. Alcohol 1997, 14, 99-105.
27. Mathews, S.; Xu, M.; Wang, H.; Bertola, A.; Gao, B. Animal models of alcohol-induced liver disease: Pathophysiology, translational relevance and challenges. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306, G819-G823.
28. Castilla, A.; Prieto, J.; Fausto, N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N. Engl. J. Med. 1991, 324, 933-940.
29. Shek, F.W.; Benyon, R.C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur. J. Gastroenterol. Hepatol. 2004, 16, 123-126.
30. Zhang, B.J.; Xu, D.; Guo, Y.; Ping, J.; Chen, L.B.; Wang, H. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clin. Exp. Pharmacol. Physiol. 2008, 35, 303-309.
31. Deng, X.S.; Deitrich, R.A. Ethanol metabolism and effects: nitric oxide and its interaction. Curr. Clin. Pharmacol. 2007, 2, 145-153.
32. Nanji, A.A.; Miao, L.; Thomas, P.; Rahemtulla, A.; Khwaja, S.; Zhao, S.; Peters, D.; Tahan, S.R.; Dannenberg, A.J. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 1997, 112, 943-951.
33. Gonzalez-Reimers, E.; Santolaria-Fernandez, F.; Martin-Gonzalez, M.C.; Fernandez-Rodriguez, C.M.; Quintero-Platt, G. Alcoholism: A systemic proinflammatory condition. World J. Gastroenterol. 2014, 20, 14660-14671.
34. Kang, K.S.; Kim, I.D.; Kwon, R.H.; Lee, J.Y.; Kang, J.S.; Ha, B.J. The effects of fucoidan extracts on CCl(4)-induced liver injury. Arch. Pharm. Res. 2008, 31, 622-627.
35. Hong, S.W.; Jung, K.H.; Lee, H.S.; Zheng, H.M.; Choi, M.J.; Lee, C.; Hong, S.S. Suppression by fucoidan of liver fibrogenesis via the TGF-beta/Smad pathway in protecting against oxidative stress. Biosci. Biotechnol. Biochem. 2011, 75, 833-840.
36. Bakhautdin, B.; Das, D.; Mandal, P.; Roychowdhury, S.; Danner, J.; Bush, K.; Pollard, K.; Kaspar, J.W.; Li, W.; Salomon, R.G.; et al. Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice. J. Hepatol. 2014, 61, 1029-1037.
37. Li, J.P.; Gao, Y.; Chu, S.F.; Zhang, Z.; Xia, C.Y.; Mou, Z.; Song, X.Y.; He, W.B.; Guo, X.F.; Chen, N.H. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol. Sin. 2014, 35, 1031-1044.
38. Zeng, T.; Zhang, C.L.; Song, F.Y.; Zhao, X.L.; Yu, L.H.; Zhu, Z.P.; Xie, K.Q. The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress. Biochim. Biophys. Acta 2013, 1830, 4848-4859.
39. Tsoyi, K.; Kim, H.J.; Shin, J.S.; Kim, D.H.; Cho, H.J.; Lee, S.S.; Ahn, S.K.; Yun-Choi, H.S.; Lee, J.H.; Seo, H.G.; et al. HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride. Cell Signal 2008, 20, 1839-1847.
40. Mandal, P.; Pritchard, M.T.; Nagy, L.E. Anti-inflammatory pathways and alcoholic liver disease: Role of an adiponectin/interleukin-10/heme oxygenase-1 pathway. World J. Gastroenterol. 2010, 16, 1330-1336.
41. Haschemi, A.; Wagner, O.; Marculescu, R.; Wegiel, B.; Robson, S.C.; Gagliani, N.; Gallo, D.; Chen, J.F.; Bach, F.H.; Otterbein, L.E. Cross-regulation of carbon monoxide and the adenosine A2a receptor in macrophages. J. Immunol. 2007, 178, 5921-5929.
42. Nishino, T.; Nishioka, C.; Ura, H.; Nagumo, T. Isolation and partial characterization of a novel amino sugar-containing fucan sulfate from commercial Fucus vesiculosus fucoidan. Carbohydr. Res. 1994, 255, 213-224.
43. Do, H.; Kang, N.S.; Pyo, S.; Billiar, T.R.; Sohn, E.H. Differential regulation by fucoidan of IFN-gamma-induced NO production in glial cells and macrophages. J. Cell Biochem. 2010, 111, 1337-1345.
44. Harrison-Findik, D.D.; Schafer, D.; Klein, E.; Timchenko, N.A.; Kulaksiz, H.; Clemens, D.; Fein, E.; Andriopoulos, B.; Pantopoulos, K.; Gollan, J. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J. Biol. Chem. 2006, 281, 22974-22982.
45. Lee, S.R.; Kwak, J.H.; Noh, S.J.; Pronto, J.R.; Ko, K.S.; Rhee, B.D.; Xu, Z.; Kim, N.; Han, J. Kobophenol A Inhibits Sodium Nitroprusside-Induced Cardiac H9c2 Cell Death through Suppressing Activation of JNK and Preserving Mitochondrial Anti-apoptotic Bcl-2 and Mcl-1. Chem. Pharm. Bull. (Tokyo) 2014, 62, 713-718.